美第奇新星生物技术 MNOV 深 沪
等待开盘 10-06 09:30:00 美东时间
1.755
-0.025
-1.40%
华盛通- 最 高3.8999
- 今 开1.82
- 成交量 18.81万股
- 最 低 1.39
- 昨 收 1.78
- 总市值 8.61万
- 52周最高 3.8999
- 市盈率 静 --
- 换手率 383.56%
- 52周最低 1.168
- 委 比 -20.63%
- 总股本 4.90万
- 历史最高 14.50
- 量 比 0.41
- 振 幅 141.01%
- 历史最低 1.10
- 每 手 1
- 风险率 0.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MediciNova Drug Falls Short on Liver Fat Parameter, Stock Tumbles
MediciNova reported Phase 2 topline trial results for tipelukast in treating NAFLD and hypertriglyceridemia.
09-28 23:10
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Kodiak Sciences (NASDAQ:KOD) shares increased by 57.4% to $50.93 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 billion. Accuray (NASDAQ:ARAY) stock moved
09-28 20:05
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) dipped 11.6% to $6.43. The company on Tuesday announced Phase 2 data for an investigational treatment for symptomatic Cerebral Cavernous Malformation (CCM). Nikola shares dipped 10.4% to $7.28 on Monday. Here are some other stocks moving in tod...
2024-09-04 01:41
MediciNova Shares Rise as Post-COVID Drug Due to Receive US Patent
12:29 PM EDT, 08/30/2024 (MT Newswires) -- MediciNova (MNOV) rose 7.3% in recent Friday trading after the company announced late Thursday that its drug MN-166 was due to receive a US patent. The US Patent and Trademark Office issued a notice of allowance that would cover the use of MN-166, or ibudil...
2024-08-31 00:29
Reported Earlier, MediciNova Receives U.S. Patent Allowance For MN-166, Ensuring Broad Protection For Post-COVID Treatment Through 2042
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), announces that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application, whi...
2024-08-30 15:53
